Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/14/2022 | MIDWEST HOLDING INC. | MDWT | Grant | Voting Common Stock | 2.7k | $0.00 | $0 | See Footnote | 06/14/2022 |
03/12/2021 | Aquestive Therapeutics, Inc. | AQST | Other (disposition) | Common Stock | 524.7k | $0.00 | $0 | See Footnotes | 03/12/2021 |
03/12/2021 | Aquestive Therapeutics, Inc. | AQST | Other (disposition) | Common Stock | 564.2k | $0.00 | $0 | See Footnotes | 03/12/2021 |
03/12/2021 | Aquestive Therapeutics, Inc. | AQST | Other (disposition) | Common Stock | 97.6k | $0.00 | $0 | See Footnotes | 03/12/2021 |
03/12/2021 | Aquestive Therapeutics, Inc. | AQST | Other (disposition) | Common Stock | 40.4k | $0.00 | $0 | See Footnotes | 03/12/2021 |
03/12/2021 | Aquestive Therapeutics, Inc. | AQST | Other (disposition) | Common Stock | 2.2M | $0.00 | $0 | See Footnotes | 03/12/2021 |
03/12/2021 | Aquestive Therapeutics, Inc. | AQST | Other (acquisition) | Common Stock | 1.8M | $0.00 | $0 | See Footnotes | 03/12/2021 |
03/09/2021 | Aquestive Therapeutics, Inc. | AQST | Gift | Common Stock | 62.5k | $0.00 | $0 | | 03/12/2021 |
02/12/2021 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 2.2M | $65.00 | $144.1M | By AKDL, L.P. | 02/12/2021 |
12/21/2020 | Denali Therapeutics Inc. | DNLI | Other (disposition) | Common Stock | 383.4k | $0.00 | $0 | By Neuro Line Partners, L.P. | 12/21/2020 |
12/14/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 16.9k | $80.35 | $1.4M | By Neuro Line Partners, L.P. | 12/11/2020 |
12/14/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 876 | $81.13 | $71.1k | By Neuro Line Partners, L.P. | 12/11/2020 |
12/11/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 46.8k | $80.05 | $3.7M | By Neuro Line Partners, L.P. | 12/11/2020 |
08/12/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 1.4M | $31.65 | $45.7M | By AKDL, L.P. | 08/12/2020 |
07/31/2020 | MIDWEST HOLDING INC. | MDWT | Grant | Stock Option (right to buy) | 50k | $0.05 | $2.5k | See Footnotes | 07/31/2020 |
06/30/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 45.1k | $24.01 | $1.1M | By Neuro Line Partners, L.P. | 06/26/2020 |
06/30/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 200 | $24.34 | $4.9k | By Neuro Line Partners, L.P. | 06/26/2020 |
06/29/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 61.8k | $23.84 | $1.5M | By Neuro Line Partners, L.P. | 06/26/2020 |
06/29/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 20.8k | $24.50 | $509k | By Neuro Line Partners, L.P. | 06/26/2020 |
06/26/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 108.5k | $23.84 | $2.6M | By Neuro Line Partners, L.P. | 06/26/2020 |
06/26/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 13.6k | $24.67 | $335.6k | By Neuro Line Partners, L.P. | 06/26/2020 |
06/23/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 16.8k | $25.69 | $430.9k | By Neuro Line Partners, L.P. | 06/19/2020 |
06/23/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 3.2k | $26.19 | $85k | By Neuro Line Partners, L.P. | 06/19/2020 |
06/22/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 65.4k | $24.66 | $1.6M | By Neuro Line Partners, L.P. | 06/19/2020 |
06/22/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 24.7k | $25.12 | $620k | By Neuro Line Partners, L.P. | 06/19/2020 |
06/19/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 82.5k | $24.20 | $2M | By Neuro Line Partners, L.P. | 06/19/2020 |
06/19/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 62.4k | $25.00 | $1.6M | By Neuro Line Partners, L.P. | 06/19/2020 |
06/16/2020 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 14k | $5.30 | $74.2k | | 06/16/2020 |
06/05/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 1.9M | $25.75 | $49.5M | By AKDL, L.P. | 06/05/2020 |
02/26/2020 | Denali Therapeutics Inc. | DNLI | Sale | Common Stock | 3.9M | $20.25 | $78.9M | By AKDL, L.P. | 02/26/2020 |
06/13/2019 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 13.4k | $4.38 | $58.5k | | 06/13/2019 |
03/25/2019 | Denali Therapeutics Inc. | DNLI | Other (disposition) | Common Stock | 158.8k | $0.00 | $0 | By Neuro Line Partners, L.P. | 03/25/2019 |
07/24/2018 | Aquestive Therapeutics, Inc. | AQST | Purchase | Common Stock | 165k | $15.00 | $2.5M | See Footnotes | 07/24/2018 |
07/24/2018 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 26.7k | $15.00 | $400.5k | | 07/24/2018 |
12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 14.5M | $0.00 | $0 | By AKDL, L.P. | 12/12/2017 |
|